← All Mutual Funds

T. Rowe Price Health Sciences Fund, Inc.

CIK: 0001002624 Equity
Report date: 2026-02-26
AUM $12.1B
Expense Ratio
Category Equity
State MD
Fiscal Year End
Inception Date
Manager
Latest Filing 2026-02-26

About this Fund

T. Rowe Price Health Sciences Fund, Inc. is a renowned mutual fund company that specializes in providing a diverse range of investment solutions to individual and institutional investors, with a strong focus on wealth management and asset management. As a trusted name in the industry, the company offers a variety of mutual funds that cater to different investment objectives and risk tolerance levels, including equity, debt, and hybrid funds. For investors seeking to capitalize on the growth potential of the healthcare sector, the T. Rowe Price Health Sciences Fund is a compelling option, leveraging the expertise of seasoned investment professionals to navigate the complexities of the health sciences industry. By adopting a disciplined and research-driven approach to investment, the company aims to deliver long-term returns that meet or exceed the expectations of its investors, while also providing a high level of transparency and accountability. The company's investment philosophy is centered on a deep understanding of the markets and a commitment to rigorous research, which enables its team of experienced portfolio managers to identify attractive investment opportunities and construct well-diversified portfolios that balance risk and potential return. For investors who prefer a systematic and disciplined approach to investing, the company offers a systematic investment plan, or SIP, which allows them to invest a fixed amount of money at regular intervals, regardless of market conditions. This approach can help reduce timing risks and promote a long-term perspective, which is essential for achieving investment success. With a strong track record of performance and a reputation for integrity and trust, T. Rowe Price Health Sciences Fund, Inc. has established itself as a trusted partner for investors seeking to grow their wealth over the long term, and its mutual funds are widely recognized as a key component of a well-diversified investment portfolio. The company's investor-focused approach is designed to provide a high level of service and support, with a dedicated team of investment professionals available to provide guidance and assistance to investors at every stage of the investment process. By prioritizing the needs and goals of its investors, T. Rowe Price Health Sciences Fund, Inc. has built a loyal client base and established itself as a leader in the mutual fund industry, with a strong reputation for delivering exceptional investment results and outstanding client service. As a specialist in asset management and wealth management, the company is well-positioned to help investors achieve their financial goals, whether they are seeking to grow their wealth, generate income, or preserve their capital. With its expertise, experience, and commitment to excellence, T. Rowe Price Health Sciences Fund, Inc. is an ideal choice for investors seeking a trusted and reliable partner to help them navigate the complexities of the investment landscape.

Holdings

From latest SEC N-PORT filing · US-listed stocks only

104 positions
# Security Name CUSIP Asset Type Weight % Value ($M) Quantity
1 ABBV ABBVIE INC Since 2026-05-10 00287Y109 Equity (Common)
2.75%
$332.37 1,454,646
2 AGIO AGIOS PHARMACEUTICALS INC Since 2026-05-10 00847X104 Equity (Common)
0.08%
$9.42 346,220
3 ALHC ALIGNMENT HEALTHCARE INC Since 2026-05-10 01625V104 Equity (Common)
0.23%
$27.70 1,402,808
4 ALKS ALKERMES PLC Since 2026-05-10 Equity (Common)
0.06%
$7.82 279,307
5 ALLO ALLOGENE THERAPEUTICS INC Since 2026-05-10 019770106 Equity (Common)
0.02%
$2.94 2,147,980
6 ALNY ALNYLAM PHARMACEUTICALS INC Since 2026-05-10 02043Q107 Equity (Common)
2.27%
$274.61 690,581
7 ANNX ANNEXON INC Since 2026-05-10 03589W102 Equity (Common)
0.01%
$1.02 204,248
8 APGE APOGEE THERAPEUTICS INC Since 2026-05-10 03770N101 Equity (Common)
0.40%
$48.15 637,936
9 ACLX ARCELLX INC Since 2026-05-10 03940C100 Equity (Common)
0.21%
$24.91 381,990
10 ARQT ARCUTIS BIOTHERAPEUTICS INC Since 2026-05-10 03969K108 Equity (Common)
0.13%
$16.27 560,191
11 ARWR ARROWHEAD PHARMACEUTICALS INC Since 2026-05-10 04280A100 Equity (Common)
0.19%
$22.44 338,015
12 AURA AURA BIOSCIENCES INC Since 2026-05-10 05153U107 Equity (Common)
0.01%
$1.39 255,721
13 AXSM AXSOME THERAPEUTICS INC Since 2026-05-10 05464T104 Equity (Common)
0.38%
$45.38 248,476
14 BEAM BEAM THERAPEUTICS INC Since 2026-05-10 07373V105 Equity (Common)
0.25%
$30.54 1,101,691
15 BBNX BETA BIONICS INC Since 2026-05-10 08659B102 Equity (Common)
0.10%
$12.06 395,769
16 BCAX BICARA THERAPEUTICS INC Since 2026-05-10 055477103 Equity (Common)
0.12%
$13.91 826,367
17 BHVN BIOHAVEN LTD Since 2026-05-10 Equity (Common)
0.07%
$8.76 775,801
18 BBOT BridgeBio Oncology Therapeutics Inc Since 2026-05-10 107924102 Equity (Common)
0.06%
$7.80 623,141
19 BBIO BRIDGEBIO PHARMA INC Since 2026-05-10 10806X102 Equity (Common)
0.55%
$66.25 866,177
20 CABA CABALETTA BIO INC Since 2026-05-10 12674W109 Equity (Common)
0.02%
$2.04 931,483
21 CAH CARDINAL HEALTH INC Since 2026-05-10 14149Y108 Equity (Common)
0.56%
$67.23 327,179
22 CAI CARIS LIFE SCIENCES INC Since 2026-05-10 142152107 Equity (Common)
0.43%
$51.72 1,916,953
23 CELC CELCUITY INC Since 2026-05-10 15102K100 Equity (Common)
0.48%
$57.43 575,794
24 CLDX CELLDEX THERAPEUTICS INC Since 2026-05-10 15117B202 Equity (Common)
0.08%
$9.76 359,422
25 COR CENCORA INC Since 2026-05-10 03073E105 Equity (Common)
0.60%
$72.81 215,573
26 CGON CG ONCOLOGY INC Since 2026-05-10 156944100 Equity (Common)
0.34%
$41.57 1,001,152
27 CLYM Climb Bio Inc Since 2026-05-10 28658R106 Equity (Common)
0.05%
$5.98 1,494,439
28 COGT COGENT BIOSCIENCES INC Since 2026-05-10 19240Q201 Equity (Common)
0.10%
$12.15 342,207
29 CBIO CRESCENT BIOPHARMA INC Since 2026-05-10 Equity (Common)
0.03%
$3.03 255,639
30 DNLI DENALI THERAPEUTICS INC Since 2026-05-10 24823R105 Equity (Common)
0.14%
$16.97 1,027,763
31 DNTH DIANTHUS THERAPEUTICS INC Since 2026-05-10 252828108 Equity (Common)
0.07%
$7.91 191,861
32 IRON DISC MEDICINE INC Since 2026-05-10 254604101 Equity (Common)
0.26%
$31.34 394,643
33 TRDA ENTRADA THERAPEUTICS INC Since 2026-05-10 29384C108 Equity (Common)
0.01%
$1.76 171,368
34 EVMN EVOMMUNE INC Since 2026-05-10 30054Y107 Equity (Common)
0.04%
$4.73 276,188
35 WGS GENEDX HOLDINGS CORP Since 2026-05-10 81663L200 Equity (Common)
0.16%
$19.05 146,500
36 GILD GILEAD SCIENCES INC Since 2026-05-10 375558103 Equity (Common)
2.17%
$261.65 2,131,780
37 DNA GINKGO BIOWORKS HOLDINGS INC Since 2026-05-10 37611X209 Equity (Common)
0.00%
$0.21 25,388
38 GH GUARDANT HEALTH INC Since 2026-05-10 40131M109 Equity (Common)
0.93%
$112.36 1,100,084
39 HTFL HEARTFLOW INC Since 2026-05-10 42238D107 Equity (Common)
0.08%
$9.97 342,110
40 HIMS HIMS & HERS HEALTH INC Since 2026-05-10 433000106 Equity (Common)
0.03%
$3.42 105,203
41 IDYA IDEAYA BIOSCIENCES INC Since 2026-05-10 45166A102 Equity (Common)
0.08%
$9.15 264,685
42 IDXX IDEXX LABORATORIES INC Since 2026-05-10 45168D104 Equity (Common)
0.74%
$89.94 132,942
43 IMNM IMMUNOME INC Since 2026-05-10 45257U108 Equity (Common)
0.39%
$46.63 2,171,072
44 IMVT IMMUNOVANT INC Since 2026-05-10 45258J102 Equity (Common)
0.11%
$13.22 520,122
45 INSP INSPIRE MEDICAL SYSTEMS INC Since 2026-05-10 457730109 Equity (Common)
0.11%
$13.30 144,206
46 ISRG INTUITIVE SURGICAL INC Since 2026-05-10 46120E602 Equity (Common)
4.48%
$541.00 955,225
47 IONS IONIS PHARMACEUTICALS INC Since 2026-05-10 462222100 Equity (Common)
0.67%
$80.67 1,019,711
48 IOVA IOVANCE BIOTHERAPEUTICS INC Since 2026-05-10 462260100 Equity (Common)
0.01%
$1.57 575,611
49 IQV IQVIA HOLDINGS INC Since 2026-05-10 46266C105 Equity (Common)
0.31%
$37.87 168,007
50 JANX JANUX THERAPEUTICS INC Since 2026-05-10 47103J105 Equity (Common)
0.01%
$1.01 72,899
51 KMTS KESTRA MEDICAL TECHNOLOGIES Since 2026-05-10 Equity (Common)
0.18%
$21.27 801,852
52 KOD KODIAK SCIENCES INC Since 2026-05-10 50015M109 Equity (Common)
0.17%
$20.29 725,750
53 KRYS KRYSTAL BIOTECH INC Since 2026-05-10 501147102 Equity (Common)
0.65%
$78.42 318,084
54 KYMR KYMERA THERAPEUTICS INC Since 2026-05-10 501575104 Equity (Common)
0.80%
$96.03 1,234,213
55 KYTX KYVERNA THERAPEUTICS INC Since 2026-05-10 501976104 Equity (Common)
0.10%
$12.41 1,320,654
56 LENZ LENZ THERAPEUTICS INC Since 2026-05-10 52635N103 Equity (Common)
0.02%
$2.73 170,941
57 MDGL MADRIGAL PHARMACEUTICALS INC Since 2026-05-10 558868105 Equity (Common)
0.30%
$36.12 62,028
58 MBX MBX BIOSCIENCES INC Since 2026-05-10 55287L101 Equity (Common)
0.16%
$19.42 615,715
59 MDWD MEDIWOUND LTD Since 2026-05-10 Equity (Common)
0.02%
$2.52 136,760
60 MRK MERCK & CO. INC. Since 2026-05-10 58933Y105 Equity (Common)
1.82%
$219.28 2,083,252
61 MIRM MIRUM PHARMACEUTICALS INC Since 2026-05-10 604749101 Equity (Common)
0.09%
$11.13 140,915
62 MOH MOLINA HEALTHCARE INC Since 2026-05-10 60855R100 Equity (Common)
0.13%
$16.01 92,264
63 GLUE MONTE ROSA THERAPEUTICS INC Since 2026-05-10 61225M102 Equity (Common)
0.15%
$18.60 1,186,156
64 MLTX MOONLAKE IMMUNOTHERAPEUTICS Since 2026-05-10 61559X104 Equity (Common)
0.08%
$9.78 742,022
65 NTRA NATERA INC Since 2026-05-10 632307104 Equity (Common)
1.07%
$129.85 566,806
66 NBIX NEUROCRINE BIOSCIENCES INC Since 2026-05-10 64125C109 Equity (Common)
0.26%
$31.62 222,974
67 NRIX NURIX THERAPEUTICS INC Since 2026-05-10 67080M103 Equity (Common)
0.21%
$25.87 1,363,852
68 NUVB NUVATION BIO INC Since 2026-05-10 67080N101 Equity (Common)
0.14%
$16.93 1,889,484
69 OLMA OLEMA PHARMACEUTICALS INC Since 2026-05-10 68062P106 Equity (Common)
0.17%
$20.63 825,139
70 OBIO ORCHESTRA BIOMED HOLDINGS INC Since 2026-05-10 68572M106 Equity (Common)
0.01%
$1.07 258,756
71 ORIC ORIC PHARMACEUTICALS INC Since 2026-05-10 68622P109 Equity (Common)
0.06%
$7.69 940,154
72 ORKA ORUKA THERAPEUTICS INC Since 2026-05-10 687604108 Equity (Common)
0.12%
$14.03 462,775
73 PALI PALISADE BIO INC Since 2026-05-10 696389402 Equity (Common)
0.02%
$2.92 1,241,126
74 PEN PENUMBRA INC Since 2026-05-10 70975L107 Equity (Common)
1.38%
$166.68 536,111
75 PTGX PROTAGONIST THERAPEUTICS INC Since 2026-05-10 74366E102 Equity (Common)
0.69%
$83.43 955,194
76 RDNT RADNET INC Since 2026-05-10 750491102 Equity (Common)
0.10%
$12.21 171,203
77 RAPP RAPPORT THERAPEUTICS INC Since 2026-05-10 75383L102 Equity (Common)
0.16%
$19.52 643,434
78 REGN REGENERON PHARMACEUTICALS Since 2026-05-10 75886F107 Equity (Common)
2.55%
$308.14 399,214
79 RLAY RELAY THERAPEUTICS INC Since 2026-05-10 75943R102 Equity (Common)
0.08%
$9.35 1,104,939
80 REPL REPLIMUNE GROUP INC Since 2026-05-10 76029N106 Equity (Common)
0.12%
$14.30 1,470,920
81 RVMD REVOLUTION MEDICINES INC Since 2026-05-10 76155X100 Equity (Common)
0.94%
$114.05 1,431,908
82 RVTY REVVITY INC Since 2026-05-10 714046109 Equity (Common)
0.24%
$28.58 295,443
83 RYTM RHYTHM PHARMACEUTICALS INC Since 2026-05-10 76243J105 Equity (Common)
0.27%
$33.11 309,295
84 RCKT ROCKET PHARMACEUTICALS INC Since 2026-05-10 77313F106 Equity (Common)
0.02%
$1.89 537,262
85 ROIV ROIVANT SCIENCES LTD Since 2026-05-10 Equity (Common)
0.60%
$71.94 3,315,138
86 SANA SANA BIOTECHNOLOGY INC Since 2026-05-10 799566104 Equity (Common)
0.02%
$1.88 462,536
87 STTK SHATTUCK LABS INC Since 2026-05-10 82024L103 Equity (Common)
0.04%
$5.43 1,488,397
88 SION SIONNA THERAPEUTICS INC Since 2026-05-10 829401108 Equity (Common)
0.22%
$26.04 633,011
89 SLNO SOLENO THERAPEUTICS INC Since 2026-05-10 834203309 Equity (Common)
0.04%
$5.20 112,291
90 SYRE Spyre Therapeutics Inc Since 2026-05-10 00773J202 Equity (Common)
0.24%
$29.37 896,465
91 SMMT SUMMIT THERAPEUTICS INC Since 2026-05-10 86627T108 Equity (Common)
1.05%
$127.44 7,286,202
92 TARS TARSUS PHARMACEUTICALS INC Since 2026-05-10 87650L103 Equity (Common)
0.25%
$30.64 374,184
93 TERN TERNS PHARMACEUTICALS INC Since 2026-05-10 880881107 Equity (Common)
0.16%
$19.29 477,405
94 TMO THERMO FISHER SCIENTIFIC INC Since 2026-05-10 883556102 Equity (Common)
4.27%
$516.02 890,534
95 RARE ULTRAGENYX PHARMACEUTICAL INC Since 2026-05-10 90400D108 Equity (Common)
0.09%
$10.41 452,583
96 URGN UROGEN PHARMA LTD Since 2026-05-10 Equity (Common)
0.09%
$10.75 459,055
97 PCVX VAXCYTE INC Since 2026-05-10 92243G108 Equity (Common)
0.17%
$21.01 455,345
98 VERA VERA THERAPEUTICS INC Since 2026-05-10 92337R101 Equity (Common)
0.83%
$99.69 1,968,700
99 VRDN VIRIDIAN THERAPEUTICS INC Since 2026-05-10 92790C104 Equity (Common)
0.16%
$19.62 630,615
100 VYGR VOYAGER THERAPEUTICS INC Since 2026-05-10 92915B106 Equity (Common)
0.01%
$1.07 273,538
101 WVE WAVE LIFE SCIENCES LTD Since 2026-05-10 Equity (Common)
0.22%
$26.00 1,529,350
102 XNCR XENCOR INC Since 2026-05-10 98401F105 Equity (Common)
0.06%
$6.70 437,762
103 XENE XENON PHARMACEUTICALS INC Since 2026-05-10 98420N105 Equity (Common)
0.04%
$5.41 120,751
104 ZTS ZOETIS INC Since 2026-05-10 98978V103 Equity (Common)
0.15%
$18.63 148,079
Frequently Asked Questions — T. Rowe Price Health Sciences Fund, Inc.
What type of mutual fund is T. Rowe Price Health Sciences Fund, Inc.?
T. Rowe Price Health Sciences Fund, Inc. is a SEC-registered Equity fund, with $12.1B in assets under management. Equity funds invest primarily in a diversified portfolio of stocks and equities, aiming for long-term capital appreciation. They carry higher market risk than bond or money market funds but historically offer stronger long-term returns. Equity mutual funds can be further classified as large-cap, mid-cap, small-cap, growth, value, or sector-specific depending on their investment mandate. As of its latest SEC N-PORT filing, T. Rowe Price Health Sciences Fund, Inc. holds 104 portfolio positions, all detailed in the holdings table on this page.
What are T. Rowe Price Health Sciences Fund, Inc.'s assets under management (AUM)?
T. Rowe Price Health Sciences Fund, Inc. has $12.1B in assets under management (AUM) according to its most recent SEC N-PORT filing on StockSifting. AUM represents the total market value of all securities and other assets held by the fund as of the report date. A larger AUM generally signals a more established fund with greater institutional adoption, more trading liquidity, and potentially lower per-unit operational costs due to economies of scale. AUM changes daily as market prices fluctuate and as investors purchase or redeem fund shares — the figure shown here reflects the most recently available N-PORT disclosure, not the current real-time value. For the live figure, consult the fund's official website or its latest SEC EDGAR filing.
What are T. Rowe Price Health Sciences Fund, Inc.'s top holdings?
According to T. Rowe Price Health Sciences Fund, Inc.'s most recent SEC N-PORT filing, the fund's largest holdings by portfolio weight include ABBVIE INC, AGIOS PHARMACEUTICALS INC, ALIGNMENT HEALTHCARE INC , among others. The complete list of all 104 holdings — including CUSIP, asset type, portfolio weight percentage, dollar value, and share quantity — is available in the holdings table above. Holdings data is sourced directly from SEC EDGAR N-PORT filings and reflects the fund's positions as of the report date shown at the top of this page. Due to the 60-day SEC disclosure lag, these positions may differ from the fund's current portfolio. For the latest holdings before public release, refer to SEC EDGAR directly.
What is T. Rowe Price Health Sciences Fund, Inc.'s expense ratio?
Expense ratio data for T. Rowe Price Health Sciences Fund, Inc. is not currently available in StockSifting's database. The expense ratio is the annual fee charged by a mutual fund as a percentage of your investment, covering management fees and operational costs. It is one of the most important factors affecting net long-term returns — lower expense ratios allow more of a fund's gross performance to flow through to investors. For the most accurate and current expense ratio, refer to the fund's official prospectus or its SEC EDGAR filings. You can also contact us if you believe this data should be present.
Where can I find T. Rowe Price Health Sciences Fund, Inc.'s SEC filings?
T. Rowe Price Health Sciences Fund, Inc. is required to file monthly portfolio reports (Form N-PORT) with the U.S. Securities and Exchange Commission (SEC). Its SEC Central Index Key (CIK) is 0001002624. You can access all of T. Rowe Price Health Sciences Fund, Inc.'s SEC filings — including N-PORT holdings disclosures, annual reports (Form N-CEN), and registration statements — directly on SEC EDGAR (CIK: 0001002624). N-PORT filings disclose the fund's complete portfolio holdings, fair value measurements, and certain risk metrics as of each filing period end date. StockSifting automatically parses these filings to populate the holdings table, AUM figures, and expense ratio displayed on this page, making the raw EDGAR data accessible without needing to download and parse XML files manually.
How current is T. Rowe Price Health Sciences Fund, Inc.'s holdings data on StockSifting?
Holdings data for T. Rowe Price Health Sciences Fund, Inc. on StockSifting is sourced from its most recent SEC EDGAR N-PORT filing. Under SEC rules, registered investment companies must file N-PORT reports monthly, but these are made publicly available approximately 60 days after the reporting period end date. This means the holdings shown on this page reflect the fund's portfolio from roughly two months prior — not today's exact positions. The Report date displayed at the top of this page indicates exactly when the underlying data was current. If the fund has made significant portfolio changes since that date — responding to market events, earnings releases, or macro shifts — those changes will not be reflected here until the next N-PORT filing is released. For the most up-to-date holdings before the public disclosure window, refer to the fund's official website or SEC EDGAR directly. StockSifting is best used for fundamental research and historical portfolio analysis, not real-time trading decisions.